CXCL12 and B-cell chronic lymphocytic leukemia: T140, and its analogs, inhibit actin polymerization and chemotaxis, suppress CXCL12-induced MAPK activation and STAT3 serine phosphorylation, and impede the migration of chronic lymphocytic leukemia (CLL) cells to stromal cells [94].